Effects of selective phosphodiesterase-5-inhibition on myocardial contractility and reperfusion injury after heart transplantation

Transplantation

Volumn 86, Issue 10, 2008, Pages 1414-1418

  Loganathan, Sivakkanan ^a   Radovits, Tamás ^a,b   Hirschberg, Kristóf ^a,b   Korkmaz, Sevil ^a   Barnucz, Eniko ^a   Karck, Matthias ^a   Szabó, Gábor ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Vardenafil, Phosphodiesterase 5, Transplantation, Ischemia reperfusion, cGMP.

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC GMP; DNA NUCLEOTIDYLEXOTRANSFERASE; VARDENAFIL; IMIDAZOLE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V; PIPERAZINE DERIVATIVE; SULFONE; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART TRANSPLANTATION; HEMODYNAMICS; ISCHEMIA; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ABDOMINAL AORTA; ANIMAL; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HETEROTOPIC TRANSPLANTATION; INFERIOR CAVA VEIN; ISOGRAFT; LEWIS RAT; METABOLISM; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; SYSTOLE;

ANIMALS; AORTA, ABDOMINAL; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; HEART TRANSPLANTATION; HEMODYNAMICS; IMIDAZOLES; MALE; MYOCARDIAL CONTRACTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SULFONES; SYSTOLE; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, ISOGENEIC; TRIAZINES; VENA CAVA, INFERIOR; VENTRICULAR FUNCTION, LEFT;

EID: 58149354275     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818aa34e     Document Type: Article

References (26)

1. Giordano D, De Stefano ME, Citro G, et al. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain. Biochim Biophys Acta 2001; 1539: 16.
2. Senzaki H, Smith CJ, Juang GJ, et al. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J 2001; 15: 1718.
3. Han J, Kim N, Kim E, et al. Modulation of ATP-sensitive potassium channels by cGMP-dependent protein kinase in rabbit ventricular myocytes. J Biol Chem 2001; 276: 22140.
4. Abdallah Y, Gkatzoflia A, Pieper H, et al. Mechanism of cGMP-mediated protection in a cellular model of myocardial reperfusion injury. Cardiovasc Res 2005; 66: 123.
5. Ockaili R, Salloum F, Hawkins J, et al. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 2002; 283: H1263.
6. Salloum FN, Ockaili RA, Wittkamp M, et al. Vardenafil: A novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. J Mol Cell Cardiol 2006; 40: 405.
7. Dias-Junior CA, Souza-Costa DC, Zerbini T, et al. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth Analg 2005; 101: 115.
8. Abdollahi M, Fooladian F, Emami B, et al. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum Exp Toxicol 2003; 22: 587.
9. Milani E, Nikfar S, Khorasani R, et al. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp Biochem Physiol C Toxicol Pharmacol 2005; 140: 251.
10. Kukreja RC, Ockaili R, Salloum F, et al. Cardioprotection with phosphodiesterase-5 inhibition - A novel preconditioning strategy. J Mol Cell Cardiol 2004; 36: 165.
11. Szabó G, Bährle S, Bátkai S, et al. Effect on reperfusion injury after heart transplantation. World J Surg 1998; 22: 791.
12. Szabó G, Fazekas L, Bährle S, et al. Endothelin-A and -B antagonist protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. Cardiovasc Res 1998; 39: 683.
13. Szabó G, Bährle S, Stumpf N, et al. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 2002; 90: 100.
14. Qian HY, Yang YJ, Huang J, et al. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Chin Med J (Engl) 2007; 120: 1416.
15. Wallace A, Lam HW, Nose PS, et al. Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg 1994; 9: 497.
16. Vinten-Johansen J, Sato H, Zhao ZQ. The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemicreperfusion injury. Int J Cardiol 1995; 50: 273.
17. Kanoria S, Jalan R, Seifalian AM, et al. Protocols and mechanisms for remote ischemic preconditioning: A novel method for reducing ischemia reperfusion injury. Transplantation 2007; 84: 445.
18. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83: 1289.
19. Beavo JA. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995; 75: 725.
20. Reffelmann S, Kloner RA. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 2003; 108: 239.
21. Wedgwood S, Steinhorn RH, Bunderson M, et al. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 2005; 289: L660.
22. Farrow KN, Groh BS, Schumacker PT, et al. Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 2008; 102: 226.
23. du Toit EF, Genade S, Carlini S, et al. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. Eur J Pharmacol 2007; 556: 115.
24. Wildhirt SM, Suzuki H, Horstman D, et al. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction. Circulation 1997; 96: 1616.
25. Wang X, Fisher PW, Xi L, et al. Essential role of mitochondrial Ca2+ activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection. J Mol Cell Cardiol 2008; 44: 105.
26. du Toit EF, Rossouw E, Salie R, et al. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 2005; 19: 23.